InvestorsHub Logo
Followers 0
Posts 842
Boards Moderated 0
Alias Born 04/19/2006

Re: None

Thursday, 01/31/2008 6:58:16 PM

Thursday, January 31, 2008 6:58:16 PM

Post# of 30387
Wow!! Their presentation starts at 8:40 PM...that seems kinda late.

Inverness Medical Innovations to Participate at 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008
http://money.cnn.com/news/newsfeeds/articles/prnewswire/NETH13431012008-1.htm

January 31, 2008: 05:16 PM EST


WALTHAM, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. , a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference being held February 5 through 7, 2008 at the Grand Hotel Hyatt in New York City. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Tuesday, February 5, 2008 at 8:40 p.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through Merrill Lynch's website at http://www.veracast.com/webcasts/ml/globalpharma08/81102144.cfm. https://events.jpmorgan.com/ A replay of the webcast will be available via the links above for approximately 3 months from the date of the webcast. During his presentation Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. His responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

Prior to the conference Inverness will also be posting an updated investor presentation to its website at www.invmed.com/presentations.cfm.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.